Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming
Chen Hu, Dongde Wu, Lequn Bao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 1353-1358
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
Tongxin Ge, Jiawen Yang, Shihui Zhou, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 323
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 129
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers
Jincheng Qiao, Zhiqing Yu, Han Zhou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 610-610
Open Access | Times Cited: 2
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation
Xiaoguang Liu, Yilei Zhang, Li Zhuang, et al.
Genes & Diseases (2020) Vol. 8, Iss. 6, pp. 731-745
Open Access | Times Cited: 104
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen, Shangwu Chen, Dongsheng Yu
Metabolites (2020) Vol. 10, Iss. 7, pp. 289-289
Open Access | Times Cited: 98
The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities
Noorhan Ghanem, Chirine El‐Baba, Khaled Araji, et al.
Chemotherapy (2021) Vol. 66, Iss. 5-6, pp. 179-191
Open Access | Times Cited: 62
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Physcion and physcion 8-O-β-glucopyranoside: A review of their pharmacology, toxicities and pharmacokinetics
XunLi, Yingjiao Liu, Shifeng Chu, et al.
Chemico-Biological Interactions (2019) Vol. 310, pp. 108722-108722
Closed Access | Times Cited: 60
Effects of Carnosic and Usnic Acid on Pentose Phosphate Pathway Enzymes: An Experimental and Molecular Docking Study
Yeliz Demir, Neslihan Öztürk, Murat Isıyel, et al.
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 8
6‐Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance
Iqra Sarfraz, Azhar Rasul, Ghulam Hussain, et al.
BioFactors (2020) Vol. 46, Iss. 4, pp. 550-562
Open Access | Times Cited: 49
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Qi Wang, Juan Liu, Ziye Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116021-116021
Open Access | Times Cited: 11
Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition
Anna C. Beielstein, Elena Izquierdo, Stuart J. Blakemore, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 12, pp. 101830-101830
Open Access | Times Cited: 4
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
Abudureyimu Tuerhong, Jin Xu, Si Shi, et al.
Cellular and Molecular Life Sciences (2021)
Open Access | Times Cited: 27
Reprogramming of central carbon metabolism in hepatocellular carcinoma
Haoming Xia, Ziyue Huang, Yi Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113485-113485
Open Access | Times Cited: 19
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
Revathy Nadhan, Srishti Kashyap, Ji Hee Ha, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 618-618
Open Access | Times Cited: 10
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Kai Wang, Xiaodan Li, Shuwei Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets
Shi-Yan Lai, Xiaojuan Zhu, Wei-Dong Sun, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 719-719
Open Access
<p>Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect</p>
Huining Tian, Xiaoyu Zhu, You Lv, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 5957-5974
Open Access | Times Cited: 27
Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism
Ibrahim H. Polat, Míriam Tarrado‐Castellarnau, Rohit Bharat, et al.
Biology (2021) Vol. 10, Iss. 2, pp. 85-85
Open Access | Times Cited: 22
Cancer Drug Resistance and Metabolic Reprogramming
Shariqa Jan, Kaneez Fatima, Abubakar Wani, et al.
(2024), pp. 183-214
Closed Access | Times Cited: 3
6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells
Jun Wu, Yong Chen, Hui Zou, et al.
Cancer Letters (2024) Vol. 601, pp. 217177-217177
Open Access | Times Cited: 3
Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities
Muhammad Adnan, Azhar Rasul, Ghulam Hussain, et al.
Current Drug Targets (2020) Vol. 22, Iss. 5, pp. 488-504
Open Access | Times Cited: 22
<p>Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth</p>
Qi Feng, Xiuru Li, Wenjing Sun, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6921-6934
Open Access | Times Cited: 19
MEK inhibition by cobimetinib suppresses hepatocellular carcinoma and angiogenesis in vitro and in vivo
Xianli Tong, Qun Wang, Dongde Wu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 523, Iss. 1, pp. 147-152
Closed Access | Times Cited: 18
Reducing NADPH Synthesis Counteracts Diabetic Nephropathy through Restoration of AMPK Activity in Type 1 Diabetic Rats
Xiao Wei, Zongshi Lu, Li Li, et al.
Cell Reports (2020) Vol. 32, Iss. 13, pp. 108207-108207
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top